Long-term tolerance to retinal ischemia by repetitive hypoxic preconditioning: role of HIF-1alpha and heme oxygenase-1
- PMID: 17389506
- DOI: 10.1167/iovs.06-1037
Long-term tolerance to retinal ischemia by repetitive hypoxic preconditioning: role of HIF-1alpha and heme oxygenase-1
Abstract
Purpose: To determine whether the duration of ischemic tolerance in the retina could be extended by repetitive presentations of the preconditioning stimulus and to begin to elucidate the mechanistic underpinnings of the resultant novel phenotype.
Methods: Adult male Swiss-Webster ND4 mice were repeatedly preconditioned with systemic hypoxia (RHP) over 12 days; 4 weeks later, the mice were subjected to 30 minutes of unilateral retinal ischemia. Protection was quantified morphologically and functionally 1 week after ischemia by histologic analyses and scotopic electroretinography, respectively. Temporal expression patterns of hypoxia-inducible factor (HIF)-1alpha and heme oxygenase (HO)-1 were measured in response to RHP and after retinal ischemia by immunoblot analysis and immunohistochemistry.
Results: Morphologic and functional protection against ischemia-induced reductions in retinal layer thicknesses and layer cell counts, and a- and b-wave amplitudes, was documented for at least 4 weeks after RHP. There was no evidence of tissue injury or dysfunction by RHP alone. Temporally associated with this period of long-term tolerance (LTT) to retinal ischemia were sustained increases in retinal levels of HIF-1alpha and HO-1 protein lasting at least 1 and 4 weeks, respectively, after the last RHP stimulus.
Conclusions: A novel form of sustained retinal ischemic tolerance is described, wherein endogenous adaptive responses triggered by repeated hypoxia afford protection against injury many weeks after the preconditioning stimulus. HIF-1alpha-mediated, long-lasting increases in retinal HO-1 expression may contribute to the LTT phenotype. Further elucidation of the genetic and molecular basis of such adaptive plasticity could provide therapeutic targets for preventing and/or treating a variety of ischemic retinopathies.
Similar articles
-
Deferroxamine preconditioning promotes long-lasting retinal ischemic tolerance.J Ocul Pharmacol Ther. 2008 Dec;24(6):527-35. doi: 10.1089/jop.2008.0082. J Ocul Pharmacol Ther. 2008. PMID: 19046123 Free PMC article.
-
Mouse models of retinal ischemic tolerance.Invest Ophthalmol Vis Sci. 2002 Jun;43(6):1903-11. Invest Ophthalmol Vis Sci. 2002. PMID: 12036997
-
Repetitive hypoxic preconditioning attenuates renal ischemia/reperfusion induced oxidative injury via upregulating HIF-1 alpha-dependent bcl-2 signaling.Transplantation. 2009 Dec 15;88(11):1251-60. doi: 10.1097/TP.0b013e3181bb4a07. Transplantation. 2009. PMID: 19996924
-
Role of hypoxia-inducible factor in cell survival during myocardial ischemia-reperfusion.Cell Death Differ. 2008 Apr;15(4):686-90. doi: 10.1038/cdd.2008.13. Epub 2008 Feb 8. Cell Death Differ. 2008. PMID: 18259200 Review.
-
Hypoxic preconditioning in renal ischaemia-reperfusion injury: a review in pre-clinical models.Clin Sci (Lond). 2021 Dec 10;135(23):2607-2618. doi: 10.1042/CS20210615. Clin Sci (Lond). 2021. PMID: 34878507 Review.
Cited by
-
Intermittent Hypoxia Promotes Functional Neuroprotection from Retinal Ischemia in Untreated First-Generation Offspring: Proteomic Mechanistic Insights.Invest Ophthalmol Vis Sci. 2020 Sep 1;61(11):15. doi: 10.1167/iovs.61.11.15. Invest Ophthalmol Vis Sci. 2020. PMID: 32910134 Free PMC article.
-
Neuron specific metabolic adaptations following multi-day exposures to oxygen glucose deprivation.Biochim Biophys Acta. 2010 Nov;1802(11):1095-104. doi: 10.1016/j.bbadis.2010.07.013. Epub 2010 Jul 23. Biochim Biophys Acta. 2010. PMID: 20656023 Free PMC article.
-
HIF-1alpha and HIF-2alpha are differentially activated in distinct cell populations in retinal ischaemia.PLoS One. 2010 Jun 14;5(6):e11103. doi: 10.1371/journal.pone.0011103. PLoS One. 2010. PMID: 20559438 Free PMC article.
-
Intermittent hypoxia conditioning as a potential prevention and treatment strategy for ischemic stroke: Current evidence and future directions.Front Neurosci. 2022 Nov 25;16:1067411. doi: 10.3389/fnins.2022.1067411. eCollection 2022. Front Neurosci. 2022. PMID: 36507357 Free PMC article. Review.
-
Enhanced Retinal Ganglion Cell Survival in Glaucoma by Hypoxic Postconditioning After Disease Onset.Neurotherapeutics. 2015 Apr;12(2):502-14. doi: 10.1007/s13311-014-0330-x. Neurotherapeutics. 2015. PMID: 25549850 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources